Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action inhibitors |
Mechanism CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC45H48F2N14O5 |
InChIKeyHYZNVNZFNOPQLO-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | China | 22 Jul 2019 |